ELI LILLY AND COMPANY Earnings Per Share (Basic)
ELI LILLY AND COMPANY (LLY) reported Earnings Per Share (Basic) of $7.95 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-05
- ELI LILLY AND COMPANY earnings per share, basic for the quarter ending 2026-06-30 was $7.95, a 26.19% increase year-over-year.
- ELI LILLY AND COMPANY earnings per share, basic for the quarter ending 2026-03-31 was $8.27, a 169.38% increase year-over-year.
- ELI LILLY AND COMPANY earnings per share, basic for the quarter ending 2025-09-30 was $6.22, a 475.93% increase year-over-year.
- ELI LILLY AND COMPANY earnings per share, basic for the quarter ending 2025-06-30 was $6.30, a 91.49% increase year-over-year.
- ELI LILLY AND COMPANY earnings per share, basic for fiscal 2025 was $23.00, a 95.58% increase from fiscal 2024.
- ELI LILLY AND COMPANY earnings per share, basic for fiscal 2024 was $11.76, a 102.06% increase from fiscal 2023.
- ELI LILLY AND COMPANY earnings per share, basic for fiscal 2023 was $5.82, a 16.02% decline from fiscal 2022.
- ELI LILLY AND COMPANY earnings per share, basic for fiscal 2022 was $6.93, a 12.68% increase from fiscal 2021.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.95 10-Q · filed 2026-08-05 | $16.22 10-Q · filed 2026-08-05 | ||
| 2026-03-31 | $8.27 10-Q · filed 2026-04-30 | |||
| 2025-12-31 | $23.00 10-K · filed 2026-02-12 | |||
| 2025-09-30 | $6.22 10-Q · filed 2025-10-30 | $15.60 10-Q · filed 2025-10-30 | ||
| 2025-06-30 | $6.30 10-Q · filed 2026-08-05 | $9.37 10-Q · filed 2026-08-05 | ||
| 2025-03-31 | $3.07 10-Q · filed 2026-04-30 | |||
| 2024-12-31 | $11.76 10-K · filed 2026-02-12 | |||
| 2024-09-30 | $1.08 10-Q · filed 2025-10-30 | $6.86 10-Q · filed 2025-10-30 | ||
| 2024-06-30 | $3.29 10-Q · filed 2025-08-07 | $5.78 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | $2.49 10-Q · filed 2025-05-01 | |||
| 2023-12-31 | $5.82 10-K · filed 2026-02-12 | |||
| 2023-09-30 | -$0.06 10-Q · filed 2024-10-30 | $3.39 10-Q · filed 2024-10-30 | ||
| 2023-06-30 | $1.96 10-Q · filed 2024-08-08 | $3.45 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | $1.49 10-Q · filed 2024-04-30 | |||
| 2022-12-31 | $6.93 10-K · filed 2025-02-19 | |||
| 2022-09-30 | $1.61 10-Q · filed 2023-11-02 | $4.78 10-Q · filed 2023-11-02 | ||
| 2022-06-30 | $1.06 10-Q · filed 2023-08-08 | $3.17 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | $2.11 10-Q · filed 2023-04-27 | |||
| 2021-12-31 | $6.15 10-K · filed 2024-02-21 | |||
| 2021-09-30 | $1.22 10-Q · filed 2022-11-01 | $4.25 10-Q · filed 2022-11-01 | ||
| 2021-06-30 | $1.53 10-Q · filed 2022-08-04 | $3.02 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | $1.49 10-Q · filed 2022-04-29 | |||
| 2020-12-31 | $6.82 10-K · filed 2023-02-22 | |||
| 2020-09-30 | $1.33 10-Q · filed 2021-10-27 | $4.49 10-Q · filed 2021-10-27 | ||
| 2020-06-30 | $1.56 10-Q · filed 2021-08-03 | $3.16 10-Q · filed 2021-08-03 | ||
| 2020-03-31 | $1.60 10-Q · filed 2021-04-30 | |||
| 2019-12-31 | $1.64 10-K · filed 2020-02-19 | $8.93 10-K · filed 2022-02-23 | ||
| 2019-09-30 | $1.37 10-Q · filed 2020-10-28 | $7.27 10-Q · filed 2020-10-28 | ||
| 2019-06-30 | $1.44 10-Q · filed 2020-07-31 | $5.86 10-Q · filed 2020-07-31 | ||
| 2019-03-31 | $4.33 10-Q · filed 2020-05-01 | |||
| 2018-12-31 | $1.11 10-K · filed 2020-02-19 | $3.14 10-K · filed 2021-02-17 | ||
| 2018-09-30 | $1.13 10-K · filed 2020-02-19 | $2.04 10-Q · filed 2019-10-25 | ||
| 2018-06-30 | -$0.25 10-K · filed 2020-02-19 | $0.92 10-Q · filed 2019-08-02 | ||
| 2018-03-31 | $1.16 10-K · filed 2020-02-19 | |||
| 2017-12-31 | -$1.58 8-K · filed 2019-10-24 | -$0.19 10-K · filed 2020-02-19 | ||
| 2017-09-30 | $0.53 8-K · filed 2019-10-24 | $1.38 10-Q · filed 2018-11-06 | ||
| 2017-06-30 | $0.96 8-K · filed 2019-10-24 | $0.85 10-Q · filed 2018-07-25 | ||
| 2017-03-31 | -$0.10 8-K · filed 2019-10-24 | |||
| 2016-12-31 | $0.73 10-K · filed 2018-02-20 | $2.59 8-K · filed 2019-10-24 | ||
| 2016-09-30 | $0.74 10-K · filed 2018-02-20 | $1.86 10-Q · filed 2017-10-27 | ||
| 2016-06-30 | $0.71 10-K · filed 2018-02-20 | $1.12 10-Q · filed 2017-07-28 | ||
| 2016-03-31 | $0.42 10-K · filed 2018-02-20 | |||
| 2015-12-31 | $0.45 10-K · filed 2017-02-21 | $2.27 10-K · filed 2018-02-20 | ||
| 2015-09-30 | $0.75 10-K · filed 2017-02-21 | $1.82 10-Q · filed 2016-10-28 | ||
| 2015-06-30 | $0.57 10-K · filed 2017-02-21 | $1.06 10-Q · filed 2016-07-28 | ||
| 2015-03-31 | $0.50 10-K · filed 2017-02-21 | |||
| 2014-12-31 | $0.40 10-K · filed 2016-02-19 | $2.23 10-K · filed 2017-02-21 | ||
| 2014-09-30 | $0.47 10-K · filed 2016-02-19 | $1.83 10-Q · filed 2015-10-30 | ||
| 2014-06-30 | $0.68 10-K · filed 2016-02-19 | $1.36 10-Q · filed 2015-07-30 | ||
| 2014-03-31 | $0.68 10-K · filed 2016-02-19 | |||
| 2013-12-31 | $0.68 10-K · filed 2015-02-19 | $4.33 10-K · filed 2016-02-19 | ||
| 2013-09-30 | $1.11 10-K · filed 2015-02-19 | $3.65 10-Q · filed 2014-10-29 | ||
| 2013-06-30 | $1.12 10-K · filed 2015-02-19 | $2.54 10-Q · filed 2014-07-28 | ||
| 2013-03-31 | $1.42 10-K · filed 2015-02-19 | |||
| 2012-12-31 | $0.75 10-K · filed 2014-02-19 | $3.67 10-K · filed 2015-02-19 | ||
| 2012-09-30 | $1.18 10-K · filed 2014-02-19 | $2.92 10-Q · filed 2013-10-30 | ||
| 2012-06-30 | $0.83 10-K · filed 2014-02-19 | $1.73 10-Q · filed 2013-07-26 | ||
| 2012-03-31 | $0.91 10-K · filed 2014-02-19 | |||
| 2011-12-31 | $3.90 10-K · filed 2014-02-19 | |||
| 2010-12-31 | $4.58 10-K · filed 2013-02-21 | |||
| 2009-12-31 | $3.94 10-K · filed 2012-02-24 | |||
| 2008-12-31 | -$1.89 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Akari Therapeutics Plc (AKTX) | $1,527.991B | -47,921.42 | |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |